Navigation Links
Isis Reports Financial Results and Highlights for 2012
Date:2/28/2013

provide us with significant value.  We established three collaborations with Biogen Idec focused on neurologic severe and rare diseases.  Biogen Idec's extensive expertise and experience in neurological diseases makes Biogen Idec an ideal partner to work with us to build a neurologic disease franchise.  In addition, we established a collaboration with AstraZeneca that allows us to broaden and expand our antisense drug discovery and development efforts and apply our antisense technology to novel oncology targets with a global leader in cancer drug development and commercialization," concluded Ms. Parshall. 

Drug Development Highlights for 2012/ Early 2013

  • Isis and Genzyme were successful in bringing KYNAMRO to the market for patients with HoFH.  These patients are at high cardiovascular risk and may not be able to reduce their LDL-C sufficiently with currently available lipid-lowering therapies. 
  • KYNAMRO was approved for marketing in the United States by the US FDA for the treatment of patients with HoFH.
  • Isis received a total of $50 million in milestone payments from Genzyme related to the NDA acceptance in 2012 and marketing approval of KYNAMRO by the FDA in 2013.
  • Genzyme continues to enroll the FOCUS FH study, which is designed to provide 60-week safety and efficacy data in FH patients to support an additional regulatory filing.  Genzyme reached an agreement with the FDA on the design of the FOCUS FH study via a Special Protocol Assessment, or SPA.
  • Genzyme submitted a request for re-examination of the EMA's negative opinion on the marketing authorization application for KYNAMRO and expects to report the outcome of the re-examination in the first half of 2013.
  • Isis received European GMP certification of its manufacturing facility for production of drug substance to support KYNAMRO commercial launch.
  • Clinical investigators presented KYNAMRO data at important car
    '/>"/>

  • SOURCE Isis Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

    Related medicine technology :

    1. NxStage Reports Record Fourth Quarter and Full-Year 2012 Financial Results
    2. Valeant Pharmaceuticals Reports 2012 Fourth Quarter Financial Results
    3. Mylan Reports a 23% Increase in Fourth Quarter 2012 Adjusted Diluted EPS to $0.65
    4. HeartWare International Reports Fourth Quarter 2012 Revenue Of $32.7 Million; Full Year 2012 Revenue Of $110.9 Million
    5. ViroPharma Incorporated Reports Fourth Quarter and Full Year 2012 Financial Results
    6. Kewaunee Scientific Reports Improved Results for Third Quarter
    7. Jazz Pharmaceuticals Reports Full Year And Fourth Quarter 2012 Financial Results
    8. Questcor Reports Fourth Quarter and Full Year 2012 Results
    9. ResearchMoz: Global MRI Systems Market to 2018 - Technological Advancements, Increasing Number of Applications and Advent of MRI Compatible Pacemakers to Drive Future Growth - Market Research Reports
    10. United Therapeutics Corporation Reports 2012 Fourth Quarter and Annual Financial Results
    11. Halozyme Reports Fourth Quarter and Year End 2012 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/3/2015)... , August 3, 2015 ... announced today that it has acquired ... Inc. for $300 million. With the acquisition, Shire ... drops combining 0.6% povidone iodine (PVP-I) and 0.1% ... treatment of infectious conjunctivitis, an ocular surface condition ...
    (Date:7/31/2015)... CHAPEL HILL, N.C. , July 31, 2015 ... to product success in the biopharmaceutical market. Patients ... the process of selecting and switching therapies. This ... and is pushing marketers, efforts toward patient-focused marketing. ... to patient engagement, marketers have learned it,s important ...
    (Date:7/31/2015)... 31, 2015 RnRMarketResearch.com adds ... research report that provides an overview of syringes ... sourced from in-house databases, secondary and primary research. ... market products pipeline spread across 124 pages, talking ... tables and 5 figures is now available at ...
    Breaking Medicine Technology:Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 2Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 3Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 4Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 5Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 6Consumers Forcing Pharmaceutical Industry to Shift its Marketing Focus from Products to Patients 2Syringes and Needles Market Products Pipeline Review 2015 Report 2Syringes and Needles Market Products Pipeline Review 2015 Report 3Syringes and Needles Market Products Pipeline Review 2015 Report 4Syringes and Needles Market Products Pipeline Review 2015 Report 5
    ... Calif., Jan. 4, 2011 Intarcia Therapeutics, Inc. today ... will present at the 29th Annual JP Morgan Healthcare ... 2011 at the Westin St. Francis Hotel in San ... About Intarcia Intarcia Therapeutics, ...
    ... Pa., Jan. 4, 2011 Owner and medical director of ... her practice and is now offering Pixel Perfect™ ... CO2 laser from Alma Lasers. "I,m very ... Cirillo-Hyland said. "As a long time provider of aesthetic laser ...
    Cached Medicine Technology:Intarcia Therapeutics Executive Chairman Kurt Graves to Present at 29th Annual JP Morgan Healthcare Conference 2Philadelphia's Victoria A. Cirillo-Hyland, M.D. Adds Alma Lasers' Pixel CO2 Laser System to Offer Fractional CO2 Laser Treatments to Patients 2
    (Date:8/3/2015)... ... August 03, 2015 , ... The art of preparing and cooking food ... side at a young age, Nasreen Zereshki was extremely eager to cook Persian cuisine. ... cookbook Recipes from My Persian Kitchen with the world. , Since Americans tend to ...
    (Date:8/3/2015)... ... August 03, 2015 , ... ... of it’s new program “Designing Secure Healthcare Systems” This three-day, highly interactive ... leaders from healthcare organizations with access to the tactics, techniques and practices required ...
    (Date:8/3/2015)... ... 03, 2015 , ... A July 9 article from USA Today ... according to the American Dental Association. According to a study by the American Dental ... million in a single year to 2.2 million a year. Dentists and ADA officials ...
    (Date:8/3/2015)... ... ... Illinois Health & Science (IHS) has completed the purchase of IBA Molecular ... IBAM NA’s cyclotron sites and research and development facilities. , “We are ... as a large manufacturing hub in Noblesville, Indiana,” said Ken Smithmier, President and CEO ...
    (Date:8/3/2015)... ... 03, 2015 , ... Constantin Vasilica, 48 from Romania wanted to have an ... after many years of suffering and using medications with strong side effects. This had ... for extra time off or wait longer hours in the waiting rooms. Instead, he ...
    Breaking Medicine News(10 mins):Health News:Persian Cuisine: Colorful and Extremely Healthy 2Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 2Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 3Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 4Health News:Los Angeles Periodontists Comment on Rising Dental Emergency Room Trips 2Health News:Los Angeles Periodontists Comment on Rising Dental Emergency Room Trips 3Health News:Illinois Health & Science Expands Nuclear Medicine Footprint With Purchase of IBA Molecular North America, Inc. 2Health News:Chinese Health Care Provider Heshoutang Now Give Patients Complimentary Online Healing Options 2Health News:Chinese Health Care Provider Heshoutang Now Give Patients Complimentary Online Healing Options 3
    ... rather than maintaining a stable weight may have an ... in the October 22 issue of Archives of Internal ... observed among women who did not take hormone therapy ... risk factor for developing breast cancer after menopause, according ...
    ... contribute to disease , , MONDAY, Oct. 22 (HealthDay News) -- Women ... more likely to develop breast cancer than women who maintain a ... when it comes to breast cancer, there,s no good time to ... gain throughout adulthood as well as weight gain at specific stages ...
    ... Greater ... Tucson Area, FT. LAUDERDALE, Fla., ... U.S., announces it is now,offering its industry-leading services in the greater Tucson, ... 111,expands its service in Arizona, which includes a location in Tempe as ...
    ... The Journal of the American Dental Association (JADA) ... publishing a global theme issue on poverty and ... worlds biomedical publications., The Council of Science Editors ... publication by science journals throughout the world of ...
    ... Ltd. (the,"Company") today announced the following with ... In late August of this year, we ... ("IntelliPharmaCeutics") had received,acceptance from the U.S. Food ... generic drug application (known as an ANDA) ...
    ... of Innovative Hypotheses, NEW YORK, Oct. 22 ... its 6th round of Novel Research,Grants-crucial funds to scientists ... why the lupus immune system so tragically attacks the,body ... national nonprofit,organization singularly devoted to pioneering innovative lupus research. ...
    Cached Medicine News:Health News:Weight gain related to postmenopausal breast cancer risk 2Health News:Weight Gain Increases Breast Cancer Risk: Study 2Health News:Neptune Society Opens Tucson, Arizona Office 2Health News:Journal of the American Dental Association spotlights poverty 2Health News:IntelliPharmaCeuitics Ltd. Announces Generic Drug Commercialization Activities 2Health News:New Round of Lupus Research Institute Awards Brings Promise of More Breakthroughs 2Health News:New Round of Lupus Research Institute Awards Brings Promise of More Breakthroughs 3Health News:New Round of Lupus Research Institute Awards Brings Promise of More Breakthroughs 4
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    Medicine Products: